NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-175-2016-0-MT-41 ANTI-KRAS-G12D T CELL RECEPTORS MT EP 17749580.1 Issued
NCI E-175-2016-0-PL-45 ANTI-KRAS-G12D T CELL RECEPTORS PL EP 17749580.1 Issued
NCI E-175-2016-0-NL-43 ANTI-KRAS-G12D T CELL RECEPTORS NL EP 17749580.1 Issued
NCI E-175-2016-0-NO-44 ANTI-KRAS-G12D T CELL RECEPTORS NO EP 17749580.1 Issued
NCI E-175-2016-0-MK-40 ANTI-KRAS-G12D T CELL RECEPTORS MK EP 17749580.1 Issued
NCI E-175-2016-0-SI-51 ANTI-KRAS-G12D T CELL RECEPTORS SI EP 17749580.1 Issued
NCI E-175-2016-0-DE-31 ANTI-KRAS-G12D T CELL RECEPTORS DE EP 17749580.1 Issued
NCI E-175-2016-0-GR-32 ANTI-KRAS-G12D T CELL RECEPTORS GR EP 17749580.1 Issued
NCI E-175-2016-0-IE-35 ANTI-KRAS-G12D T CELL RECEPTORS IE EP 17749580.1 Issued
NCI E-175-2016-0-IS-34 ANTI-KRAS-G12D T CELL RECEPTORS IS EP 17749580.1 Issued
NCI E-175-2016-0-HU-33 ANTI-KRAS-G12D T CELL RECEPTORS HU EP 17749580.1 Issued
NCI E-175-2016-0-IT-36 ANTI-KRAS-G12D T CELL RECEPTORS IT EP 17749580.1 Issued
NCI E-175-2016-0-LU-39 ANTI-KRAS-G12D T CELL RECEPTORS LU EP 17749580.1 Issued
NCI E-175-2016-0-LV-37 ANTI-KRAS-G12D T CELL RECEPTORS LV EP 17749580.1 Issued
NCI E-175-2016-0-LT-38 ANTI-KRAS-G12D T CELL RECEPTORS LT EP 17749580.1 Issued
NCI E-175-2016-0-SE-53 ANTI-KRAS-G12D T CELL RECEPTORS SE EP 17749580.1 Issued
NCI E-175-2016-0-ES-52 ANTI-KRAS-G12D T CELL RECEPTORS ES EP 17749580.1 Issued
NCI E-175-2016-0-TR-56 ANTI-KRAS-G12D T CELL RECEPTORS TR EP 17749580.1 Issued
NCI E-175-2016-0-CH-54 ANTI-KRAS-G12D T CELL RECEPTORS CH EP 17749580.1 Issued
NCI E-175-2016-0-EE-28 ANTI-KRAS-G12D T CELL RECEPTORS EE EP 17749580.1 Issued
NCI E-175-2016-0-FR-30 ANTI-KRAS-G12D T CELL RECEPTORS FR EP 17749580.1 Issued
NCI E-175-2016-0-DK-27 ANTI-KRAS-G12D T CELL RECEPTORS DK EP 17749580.1 Issued
NCI E-175-2016-0-FI-29 ANTI-KRAS-G12D T CELL RECEPTORS FI EP 17749580.1 Issued
NCI E-175-2016-0-GB-55 ANTI-KRAS-G12D T CELL RECEPTORS GB EP 17749580.1 Issued
NCI E-175-2016-0-JP-07 ANTI-KRAS-G12D T CELL RECEPTORS JP National Stage 2019-505220 Issued
NHLBI E-124-2014-3-US-03 Devices and Methods For Closure Of Transvascular Or Transcameral Access Ports US National Stage 15/664,642 10045765 Issued PDF
NCI E-175-2016-0-PCT-02 ANTI-KRAS-G12D T CELL RECEPTORS PCT PCT PCT/US2017/044615 Expired
CC E-096-2016-0-PCT-02 POWERED GAIT ASSISTANCE SYSTEMS PCT PCT PCT/US2017/044625 Expired
NIAID E-109-2007-1-US-15 DETECTION OF INFECTIOUS PRION PROTEIN BY SEEDED CONVERSION OF RECOMBINANT PRION PROTEIN US CON 15/665,323 Abandoned
NIAID E-020-2018-0-CN-05 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN CN National Stage 201680008108.2 Abandoned
NCI E-175-2016-0-CA-04 ANTI-KRAS-G12D T CELL RECEPTORS CA National Stage 3032870 Pending
NIAID E-020-2018-0-MX-03 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN MX National Stage MX/a/2017/009889 Abandoned
NIAID E-181-2016-0-PCT-02 Zika Virus Vaccines PCT PCT PCT/US2017/044468 Expired
CC E-277-2015-0-PCT-02 TRANSPERINEAL IMAGING-GUIDED PROSTATE NEEDLE PLACEMENT PCT PCT PCT/US2017/044344 Expired
NCI E-193-2017-0-US-01 Ultrasound Sensitive Peptide Nanoparticles For Spatially Resolved Molecule Delivery US 62/538,116 Abandoned
NIAID E-020-2018-0-US-04 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN US National Stage 15/547,365 Abandoned
NIAID E-060-2015-0-KR-12 NOVEL POLYVALENT NANOPARTICLE-BASED VACCINE KR National Stage 10-2017-7021112 Issued
NIAID E-300-2009-5-US-11 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US DIV 15/661,867 10035845 Issued PDF
NIDDK E-121-2019-2-US-01 ADENOSINE KINASE ISOFORM-SPECIFIC CANCER TREATMENT US 62/537,879 Abandoned
NCI E-040-2012-0-AU-25 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2017208279 Issued
NCATS E-046-2018-1-US-01 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISEASES VIA AUTOPHAGY INDUCTION US 62/537,260 Abandoned
NHLBI E-121-2016-1-SG-05 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE SG National Stage 11201810871W Issued
NHLBI E-121-2016-1-HK-07 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE HK EP 19130894.9 Issued
NHLBI E-121-2016-1-IE-13 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE IE EP 17754517.5 Issued
NHLBI E-121-2016-1-DE-09 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE DE EP 17754517.5 Issued
NHLBI E-121-2016-1-FR-10 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE FR EP 17754517.5 Issued
NHLBI E-121-2016-1-CH-08 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE CH EP 17754517.5 Issued
NHLBI E-121-2016-1-GB-11 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE GB EP 17754517.5 Issued
NHLBI E-121-2016-1-EP-03 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE EP National Stage 17754517.5 Issued
NIBIB E-232-2014-0-US-04 Resolution Enhancement for Light Sheet Microscopy Systems and Methods US National Stage 15/511,580 10401604 Abandoned PDF